Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy.
Yanagita T, Murata Y, Tanaka D, Motegi SI, Arai E, Daniwijaya EW, Hazama D, Washio K, Saito Y, Kotani T, Ohnishi H, Oldenborg PA, Garcia NV, Miyasaka M, Ishikawa O, Kanai Y, Komori T, Matozaki T.
Yanagita T, et al.
JCI Insight. 2017 Jan 12;2(1):e89140. doi: 10.1172/jci.insight.89140.
JCI Insight. 2017.
PMID: 28097229
Free PMC article.